Can AI Be Licensed the Way Doctors and Nurses Are?
A Licensure Model May Offer Safer Oversight as Clinical AI Grows More Complex, a Penn LDI Doctor Says
Research & Policy Updates
Venture Philanthropy Transformed Cystic Fibrosis. Can It Deliver for Other Diseases?
CF Foundation’s Landmark Drug Approvals With Vertex Inspired Patient Groups to Act Like Biotech Investors. But Only a Few Groups Have Made Big Bets, LDI Fellow Finds
Patients Face New Barriers for GLP-1 Drugs Like Wegovy and Ozempic
Even With Lower Prices, Medicare, Medicaid, and Other Insurers Tighten Coverage for Drugs Like Mounjaro and Zepbound Using Prior Authorization and Other Tools
Heart Failure Patients May Get Sicker When the Rent Is Too High
Cheaper Housing Could be a Way to Lower Hospitalizations Among Medicaid Patients with Heart Failure
How One Study Helped Save Free Preventive Care in a Supreme Court Showdown
A 2024 Study Showing How Even Small Copays Reduce PrEP Use Fueled Media, Legal, and Advocacy Efforts As Courts Weighed a Case Threatening No-Cost Preventive Care for Millions
How Playing Games May Save People’s Lives
The Growing Use of Gamification in Health Motivates People to Exercise More and Take Other Actions to Improve Their Physical Well-Being
Impact: LDI Fellows Shaped Public Discussion and Public Policy in 2025
Highlighting 10 Ways LDI Fellows Put Their Research Into Action
10 Noteworthy Research Articles from LDI in 2025
From AI-Powered Public Health Messaging to Stark Divides in Child Wellness and Medicaid Access, LDI Experts Highlight Urgent Problems and Compelling Solutions
Applying for SNAP Just Got Harder—But New Evidence Shows Making It Easier May Cut Hunger
Administrative Hurdles, Not Just Income Rules, Shape Who Gets Food Assistance, LDI Fellows Show—Underscoring Policy’s Power to Affect Food Insecurity
Insurers’ Utilization Management Tools Vary Widely on Anti-Nausea Drugs for Cancer
Chart of the Day: LDI Researchers Report Major Coverage Differences Across ACA and Medicaid Plans, Affecting Access to Drugs That Treat Chemo-Related Nausea
Why You May Have Fewer Health Insurance Choices Than Your Neighbor
Insurers Avoid Counties With Small Populations and Poor Health but a New LDI Study Finds Limited Evidence of Anticompetitive Behavior
Do Direct-to-Consumer Drug Ads Do More Good Than Harm?
The Evidence Suggests a Ban on Ads May Not Be A Well-Targeted Solution